High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity

SIMPLE SUMMARY: No standard treatment is defined for relapsed or refractory (r/r) primary CNS lymphoma (PCNSL). However, high-dose chemotherapy with autologous stem cell transplantation (HCT-ASCT), an efficient first line treatment in younger PCNSL patients, is commonly applied in relapsed or refrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidel, Sabine, Nilius-Eliliwi, Verena, Kowalski, Thomas, Vangala, Deepak Ben, Schlegel, Uwe, Schroers, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106040/
https://www.ncbi.nlm.nih.gov/pubmed/35565230
http://dx.doi.org/10.3390/cancers14092100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106040/
https://www.ncbi.nlm.nih.gov/pubmed/35565230
http://dx.doi.org/10.3390/cancers14092100

Ejemplares similares